CLINICAL_TRIALS
trial_result
· 2019-11-21
Clinical Trial Update: Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML) [Phase 1, Phase 2]
Summary
Phase 1/2 trial evaluating PLX3397 in adults with relapsed or refractory acute myeloid leukemia completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Daiichi Sankyo | Conditions: Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-11-21